Issue 1, 2017

Cyclometalated Ir(iii) complexes containing quinoline–benzimidazole-based N^N ancillary ligands: structural and luminescence modulation by varying the substituent groups or the protonation/deprotonation state of imidazole units

Abstract

Cyclometalated Ir(III) complexes [Ir(dfppy)2(qbiH)](PF6) (1), [Ir(dfppy)2(qbim)](PF6)·H2O (2), [Ir(dfppy)2(qbio)](PF6) (3) and [Ir(dfppy)2(qbi)] (4) have been designed and prepared, in which the N^N ligands qbiH, qbim and qbio incorporate different substituent groups R on their imidazole units (H atom, CH3 group and n-C8H17 group, respectively) in order to explore the influence of the substituent groups R and the protonation/deprotonation state of imidazole units in these Ir(III) complexes on their structures and luminescence behaviors. Crystal structures indicate that an {Ir(dfppy)2}+ unit is coordinated by neutral ligands qbiH in 1, qbim in 2 and qbio in 3, while a qbi anion in 4. These Ir(III) complexes show clearly different molecular stacking modes. In compound 1, neighboring [Ir(dfppy)2(qbiH)]+ cations are linked into a supramolecular chain through π⋯π stacking interactions between adjacent dfppy/qbiH ligands. In 2 and 4, two neighboring iridium complex units connect each other through π⋯π stacking interactions between dfppy ligands in the former, while between qbi ligands in the latter, forming supramolecular dimers. Compared to 1, 2 and 4, compound 3 only exhibits intermolecular van der Waals interactions. At room temperature, these Ir(III) complexes in CH2Cl2 reveal phosphorescence with a mixing of 3MLCT and 3LC characters, emissions at 558 and 585 nm for 1, 572 (or 573) and 600 nm for 2 and 3, and 546 nm for 4. Compared to 1–3, compound 4 displays relatively weak luminescence intensity. Interestingly, upon addition of NEt3/TFA, both 1 and 4 in CH2Cl2 can switch their luminescence between strong emission at 558 nm and weak emission at 546 nm, due to their acid-/base-induced structural interconversion between the protonation state and the deprotonation state of the qbiH ligand. The emissions of 1–4 in the solid state reveal different degrees of the red shift compared to their corresponding emissions in CH2Cl2, the broad emission bands at 542, 572 and 611 nm for 1, 553, 581 and 612 nm for 2, 544, 578 and 630 nm for 3, and 595 and 633 nm for 4. Based on the crystal structures of 1–4, this work discusses the luminescence modulation of these Ir(III) complexes by varying their substituent groups or the protonation/deprotonation state of the imidazole units.

Graphical abstract: Cyclometalated Ir(iii) complexes containing quinoline–benzimidazole-based N^N ancillary ligands: structural and luminescence modulation by varying the substituent groups or the protonation/deprotonation state of imidazole units

Supplementary files

Article information

Article type
Paper
Submitted
25 Oct 2016
Accepted
29 Nov 2016
First published
29 Nov 2016

Dalton Trans., 2017,46, 275-286

Cyclometalated Ir(III) complexes containing quinoline–benzimidazole-based N^N ancillary ligands: structural and luminescence modulation by varying the substituent groups or the protonation/deprotonation state of imidazole units

D. Gong, T. Gao, D. Cao and M. D. Ward, Dalton Trans., 2017, 46, 275 DOI: 10.1039/C6DT04091H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements